This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: **The Innovative Mind of Boris P. Surinov**
Introduction
Boris P. Surinov, an inventive mind based in Ogbninsk, Kaluzhskaya oblast, has made strides in the field of antiviral research. His innovation focuses on developing chemical compounds that could potentially revolutionize the way we approach viral infections. With a solid foundation in his research, Surinov has gained recognition through his significant patent, contributing to the ongoing fight against viral diseases.
Latest Patents
Surinov holds a notable patent involving an indole derivative that has proven to have antiviral properties and the ability to induce interferon. This compound showcases his dedication to enhancing medical solutions through innovative chemistry and biochemistry.
Career Highlights
Throughout his career, Boris has focused on research that bridges the gap between chemistry and medicine. His work emphasizes not only the scientific principles behind his inventions but also their practical applications. Surinov’s commitment to advancing antiviral treatments is a testament to his innovative spirit and dedication to improving public health.
Collaborations
In his journey of innovation, Surinov has collaborated with talented colleagues such as Fedor A. Trofimov and Nina G. Tsyshkova. These partnerships have contributed to a dynamic exchange of ideas and scientific expertise, further enhancing the quality and impact of their research.
Conclusion
Boris P. Surinov stands out as a prominent inventor in the landscape of pharmaceutical innovation. His dedication to creating effective antiviral agents underscores his role as a critical contributor to scientific advancement. The combination of his innovative ideas and collaborative efforts promises a bright future in the realm of antiviral research and treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile